SCHEMBL2304154

SCHEMBL2304154

Nc1ccc(C(=O)N2CC3CCCC(C2)N3C(=O)O)cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 1/20 0.45
GABRD O14764 1/20 0.45
GABRA1 P14867 1/20 0.45
GABRB1 P18505 1/20 0.45
GABRG2 P18507 1/20 0.45
GABRB3 P28472 1/20 0.45
GABRA5 P31644 1/20 0.45
GABRA3 P34903 1/20 0.45
GABRA2 P47869 1/20 0.45
GABRB2 P47870 1/20 0.45
GABRA4 P48169 1/20 0.45
GABRE P78334 1/20 0.45
GABRA6 Q16445 1/20 0.45
GABRG1 Q8N1C3 1/20 0.45
GABRG3 Q99928 1/20 0.45
GABRQ Q9UN88 1/20 0.45
NNMT P40261 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
L3MBTL3 Q96JM7 3/20 0.41
L3MBTL1 Q9Y468 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2301926 0.83 HDAC1 (0.48) PIK3CAMTORHDAC1CDK4
SCHEMBL12426761 0.79 CDK4 (0.51) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL12425623 0.78 CDK4 (0.49) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL2300794 0.77 HDAC1 (0.52) HDAC1CDK4
SCHEMBL12425265 0.76 GABRP (0.46) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL6173203 0.74 HPGD (0.59) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL12426731 0.73 CDK1 (0.47) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL12425269 0.73 CDK4 (0.50) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL10726108 0.73 HPGD (0.61) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL23089250 0.73 CHRNB2 (0.44) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2536730-A1 PYRROLOPYRIMIDINE COMPOUNDS AS INHIBITORS OF CDK4/6 Novartis AG (CH) 2012-12-26 EP disclosed
WO-2011101409-A1 PYRROLOPYRIMIDINE COMPOUNDS AS INHIBITORS OF CDK4/6 NOVARTIS AG (CH) 2011-08-25 WO disclosed